|
The Economist April loth zozr
<br />Covid-ug vaccines
<br />Sorting signal
<br />from noise
<br />With millions vaccinated, rare side-
<br />effects of covid jabs are coming to light
<br />CHR[s wHrrrY, England's chief medical
<br />officer, vividly recalls a nerve-raciaog
<br />moment on December 8th 2020. That was
<br />the day when England became the first
<br />country to roll out a covid-r9 vaccine, a jab
<br />developed by Pfizer and BioNTech. Near
<br />in idWght on vaccination day one "we were
<br />discussing it and just thinking 'what are
<br />we dealing with here? These are small
<br />numbers and we've already had several
<br />dangerous near misses'.- said Dr Whitty in
<br />a recent talk at the Royal Society of Medi-
<br />ae. In somepcople, it had turned out, the
<br />vaccine sets off anaphylaxis, a life-threat-
<br />ening
<br />fe-threatening allergic reaction. But this is rare. It
<br />occurred just once among the 22,000 or so
<br />people vaccinated in the trial. which could
<br />have been by chance. Now, with hundreds
<br />of millions vaccinated, the rate at which it
<br />occurs is cleaner: five per million.
<br />Fortunately, this side-effect is not only
<br />extremely rare but shows up soon after the
<br />jab. And treatment for it exists. Everyone
<br />who receives the Pflrxr vaccine is now
<br />asked to stidcaround fuorc5 minutes, just in
<br />case. There have been no deaths from ana-
<br />phylaxis related to the vaccine
<br />As millions of jabs of various covid-tg
<br />vaccines are administered every day, such
<br />rare adverse reactions will inevitably
<br />emerge. On April 7th both Britain's health
<br />officials and the European Medicines
<br />Agency (caw), which regulates drugs in the
<br />European Union. said there is strong evi-
<br />dence that AstraZeneca's covid-r9 vaccine
<br />may be unload with very tare blood clots,
<br />often in the brain or the abdomen. The Em
<br />expects reached their conclusion based on
<br />a review of 86 reported cases, r8 of which
<br />were fatal. Britain's experts reached the
<br />same conclusion from data on 79 cases, h9
<br />of which were fatal. Both the FmA and Brit-
<br />ain's drug regulator concluded that the
<br />vaccines benefits outweigh the potential
<br />risk of the dots. But Britain's officials,
<br />armed as usual with some nifty charts for
<br />their televised briefing, said thatforpeople
<br />under ;o the risks and benefits from the
<br />vaccine were 'finely balanced", so a differ-
<br />ent jab may be preferable.
<br />The investigation of the suspected clots
<br />from the Astra7eneca jab has been a prime
<br />exampleofrhe challenge ofsortingthe sig-
<br />nal of a vaccine's side-effects from the ca-
<br />cophony of medical emergencies that hap-
<br />pen to millions of people every day. Vac-
<br />cine -safety experts have two ways to un-
<br />lve whether a rare medical proh]em is
<br />Pla� at work
<br />caused by a vaccine, says lcathryn Edwards
<br />of the Vanderbilt University school of
<br />Medicine, In Nashville, Tennessee. They
<br />can compare its rate in vaccinated people
<br />against the `background' rates ofit thatare
<br />observed in the unvaccinated. And they
<br />an look for unusual features of the medi-
<br />cal condition being investigated_
<br />The fust signals emerged in late Febru-
<br />ary, when doctors in several European
<br />countries noticed clusters of blood dots In
<br />people recently given the AstraZeneca jab,
<br />someofwhom died- Most were women un-
<br />der 6o, which was not terribly surprising
<br />because many EU countries were, at first,
<br />not convinced that the jab worked in the el-
<br />derly and used it largely for essential work-
<br />ers, such as nurses, teachers and social -
<br />care workers—professions in which most
<br />employees are women.
<br />The FMA's data as of March 22nd sug-
<br />gested that the tate of brain clots in people
<br />under the age of 6o who bad bad Astra-
<br />Zenecas vaccine was one in hoo,000—
<br />higher than would be expected normally.
<br />Precisely how much higher, though, is
<br />hard to tell. The rates of such rareand diffi-
<br />cuit-to-diagnose conditions vary a lot by
<br />country, age and sex. Estimates of the inci-
<br />dence of such brain dots have ranged from
<br />0.22 to 1.57 cases per too,000 people per
<br />year, and they, are more common in youn-
<br />gerpeopleand women.
<br />As doctors began to look more closely,
<br />something curious emerged Many pa-
<br />tients with suspected clots from the vac-
<br />cine had unusually low levels of platelets.
<br />These are fragments of special precursor
<br />cells that float in the blood Their job is to
<br />form blood clots (they rush to the site of a
<br />ort or other bleeding). Cow platelet levels
<br />therefore usually result in uncontrolled
<br />bleeding, not dots.
<br />Comments on the Draft CAP 2.0
<br />2021.12.22
<br />Science & technology 73
<br />with this new information to hand,
<br />Britain's medical regulators searched their
<br />data on vaccinated people for the unusual
<br />tandem of clots and low platelet counts.
<br />They found four cases per million people
<br />vaccinated, a rate several times lower than
<br />in the EU. One explanation is that Britain,
<br />unlike the rest of Europe, had used the jab
<br />primarily in older people. The rateat which
<br />the clots occurred in Britain declined
<br />steadily with age. importantly, Britain's ex-
<br />perts found that the clots occurred as
<br />much in men as they did in women.
<br />This combination of blood dots and
<br />low platelet counts is something that doc-
<br />tors know bow to diagnose and treat, says
<br />Jean Marie Connors, a haematologist at
<br />Brigham and women's Hospital, in Boston.
<br />It resembles a condition seen is some peo-
<br />ple who are given heparin, a drug used
<br />widely to treat blood dots. For unknown
<br />reasons, some people develop an immune
<br />reaction to heparin, which results in blood
<br />dotting so profound that it depletes their
<br />platelets. The same reaction appears to be
<br />provoked by the vaccine.
<br />Medical societies in several countries
<br />have already issued guidelines to doctors
<br />on how to spot and treat this rare reaction
<br />to the AstraZeneca vaccine. With vigilance
<br />and appropriate care, the extremely rare
<br />deaths that may result from it will become
<br />even rarer a
<br />Dorn-ast3c hcating
<br />A new use for
<br />microwaves
<br />U you can have microwave ovens, why
<br />rot microwave boilug
<br />DECARBONISING AN BODNOMY i5 a big
<br />job. Coal- and gas -fined power plants
<br />must be swapped for wind, solaror nuclear
<br />ones. Petrol -driven cars must be replaced
<br />by electric versions. Less attention is paid
<br />to beating. But in cold countries such as
<br />Britain, warming houses, offices and the
<br />like consumes more fossil fuel than etcher
<br />electricity generation or transport
<br />The fuel involved is usually natural gas.
<br />This is burned in aceatral boilerin orderto
<br />heat water that flows to radiators else-
<br />where in the building. Britain's govern-
<br />ment would like to change this. From 2025
<br />gas -fined boilers will be banned in newly
<br />built homes. By the mid-2o3os installing
<br />new gas boilers in existing houses will be
<br />banned, too.
<br />The question Is what will replace them.
<br />Unlike electricity generation, where re-
<br />newables are proving popular, or ars,
<br />where battery -powered vehicles are rapid-
<br />ly becoming established, the market for �►
<br />
|